Literature DB >> 28334840

Review of Caffeine-Related Fatalities along with Postmortem Blood Concentrations in 51 Poisoning Deaths.

Alan Wayne Jones1.   

Abstract

Publications reporting concentrations of caffeine in postmortem blood were reviewed if the cause of death was attributed to overdosing (poisoning) with drugs. Age and gender of the deceased, the manner of death (accident, suicide or undetermined) and types of co-ingested drugs were evaluated in relation to the concentrations of caffeine in blood (N = 51). The mean age (±SD) of the victims was 39 ± 17.8 years (range 18-84 years) and most were female (N = 31 or 61%). The difference in mean age of males (42 ± 17.2 years) and females (37 ± 18.3 years) was not statistically significant (t = 0.811, P = 0.421). The mean (±SD), median and range of caffeine concentrations in postmortem blood were 187 ± 96 mg/L (180 mg/L) and 33-567 mg/L, respectively. The median concentration of caffeine in males (161 mg/L) was not significantly different from that of females (182 mg/L), z = 1.18, P = 0.235. There was no correlation between the age of the deceased and the concentration of caffeine in postmortem blood (R2 = 0.026, P > 0.05). Manner of death was classified as suicide in 51% of cases (median blood-caffeine 185 mg/L), accidental in 16% (median 183 mg/L) or undetermined in 33% (median 113 mg/L). The median concentration of caffeine in blood was lower when manner of death was undetermined compared with suicide or accidental (P = 0.023). Although other drugs, including ethanol, antidepressants, antipsychotics, benzodiazepines and/or ephedrine, were often identified in postmortem blood, the predominant psychoactive substance was caffeine. The deceased had ingested caffeine in tablet or powder form and it does not seem likely that toxic concentrations of caffeine can be achieved from over-consumption of caffeinated beverages alone.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28334840     DOI: 10.1093/jat/bkx011

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  8 in total

1.  Massive β1-Adrenergic Receptor Reaction Explains Irreversible Acute Arrhythmia in a Fatal Case of Acute Pure Caffeine Intoxication.

Authors:  Aniello Maiese; Raffaele La Russa; Zoe Del Fante; Emanuela Turillazzi; Maria Chiara David; Paola Frati; Vittorio Fineschi
Journal:  Cardiovasc Toxicol       Date:  2020-09-11       Impact factor: 3.231

2.  Suicide by ingestion of caffeine.

Authors:  Frédéric Aknouche; Emilie Guibert; Alison Tessier; Aude Eibel; Pascal Kintz
Journal:  Egypt J Forensic Sci       Date:  2017-07-19

Review 3.  The clinical toxicology of caffeine: A review and case study.

Authors:  Cyril Willson
Journal:  Toxicol Rep       Date:  2018-11-03

4.  Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes.

Authors:  Ehab Hamed
Journal:  Eur J Case Rep Intern Med       Date:  2018-10-24

5.  Urinary glucose and ketone bodies as indicators of acute caffeine poisoning.

Authors:  Seiji Morita; Tomoatsu Tsuji; Mari Amino; Naoya Miura; Takeshi Saito; Yoshihide Nakagawa
Journal:  Acute Med Surg       Date:  2020-03-16

6.  Caffeine Intoxication: Unregulated, Over-the-Counter Sale of Potentially Deadly Supplements.

Authors:  João Pina Cabral; David L Sousa; Catarina Carvalho; Adriana Girao; Adriano Pacheco Mendes; Rui Pina
Journal:  Cureus       Date:  2022-01-09

Review 7.  Caffeine-Related Deaths: Manner of Deaths and Categories at Risk.

Authors:  Simone Cappelletti; Daria Piacentino; Vittorio Fineschi; Paola Frati; Luigi Cipolloni; Mariarosaria Aromatario
Journal:  Nutrients       Date:  2018-05-14       Impact factor: 5.717

8.  Methylxanthines: Potential Therapeutic Agents for Glioblastoma.

Authors:  Daniel Pérez-Pérez; Iannel Reyes-Vidal; Elda Georgina Chávez-Cortez; Julio Sotelo; Roxana Magaña-Maldonado
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.